![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » SHIRE ADDERALL XR PARAGRAPH IV NOTICE RECEIVED FROM ANDRX
SHIRE ADDERALL XR PARAGRAPH IV NOTICE RECEIVED FROM ANDRX
Shire announces Tuesday that it has received a Paragraph IV notice letter from Andrx Pharmaceuticals, L.L.C. (Andrx) advising of the filing of an Abbreviated New Drug Application (ANDA) for its amphetamine combination product, a generic version of Shire's mixed amphetamine salt product, ADDERALL XR.
Easy Bourse (http://www.easybourse.com/Website/dynamic/News.php?NewsID=66065&lang=fra&NewsRubrique=2)
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
11Jul
-
18Jul
-
21Oct